AVMA Advocate – December 2021

AVMA Advocate – December 2021

Ensuring veterinarians have access to compounded products 

The Food and Drug Administration (FDA) is in the process of finalizing a guidance document on the use of bulk drug substances for compounding animal medications. As currently written, the draft guidance would not allow the use of compounds made from bulk drug substances to be kept in office stock for administration or dispensing by a veterinarian unless the compound is identified on a list maintained by the FDA.

The AVMA has previously filed comments opposing the use of a list in this manner. As the details of the final guidance become available, the AVMA will evaluate the impact to practice and work to ensure veterinarians have appropriate access to the compounded medications needed to treat our patients.

Continue reading



X
X